CDKN2A Gene Mutations: Implications for Hereditary Cancer Syndromes.

Area of Science:

• Oncology
• Genetics
• Hereditary Cancer Syndromes

Background:

• Malignant neoplasms, including pancreatic cancer and melanoma, pose significant global health challenges.
• Melanoma pancreatic syndrome is a rare hereditary tumor syndrome linked to CDKN2A gene mutations.
• CDKN2A mutations are associated with a substantial lifetime risk of developing melanoma (28-67%).

Purpose of the Study:

• To investigate the clinical features of individuals with CDKN2A mutations.
• To identify recurrent CDKN2A alterations associated with hereditary cancer.
• To highlight the need for genetic testing in suspected familial atypical multiple mole melanoma cases.

Main Methods:

• Clinical data collection from six individuals with CDKN2A mutations.
• Identification of recurrent genetic alterations (e.g., c.307_308del, c.159G>C, c.71G>C).
• Review of existing literature on CDKN2A mutations and associated cancers.

Main Results:

• Six individuals with CDKN2A mutations presented with specific clinical features.
• Recurrent CDKN2A alterations, including c.307_308del, c.159G>C, and c.71G>C, were identified.
• Clinically significant variants were associated with both melanoma and pancreatic cancer.

Conclusions:

• CDKN2A mutation testing is recommended for individuals with suspected familial atypical multiple mole melanoma.
• Effective targeted therapies for CDKN2A-associated cancers are lacking, necessitating further research.
• Continued investigation into diagnostic and therapeutic strategies is essential for hereditary cancer syndromes.